HIV trials in United States
364 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesCombating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
- Where
- Minneapolis
- Age
- 18 years to 99 years
- People
- 155
- Run by
- University of Minnesota
See details and how to joinNCT06975176 - Phase 4Taking peopleCabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
- Where
- Atlanta, Aurora, Baltimore, Chicago, Houston, La Jolla, Los Angeles, Memphis, Philadelphia, The Bronx
- Age
- 18 years and over
- People
- 40
- Run by
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
See details and how to joinNCT07637942 - No phaseTaking peopleParadoxical Tuberculosis Reactions in Patients Without HIV Infection
- Where
- Bethesda
- Age
- 18 years to 99 years
- People
- 140 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT04052022 - No phaseEnrolling by invitationEvaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection
- Where
- Ann Arbor, New York
- Age
- 17 years to 65 years
- People
- 384
- Run by
- Hunter College of City University of New York
See details and how to joinNCT05833074 - No phaseTaking peopleBehavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
- Where
- Los Angeles, Providence
- Age
- 16 years to 24 years
- People
- 360
- Run by
- Westat
See details and how to joinNCT06444360 - Phase 1Not yet taking people in United StateshuCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 6
- Run by
- University of Pennsylvania
See details and how to joinNCT07891468 - No phaseNot yet taking people in United StatesCardiovascular Disease Multimorbidity
- Where
- New York
- Age
- 30 years and over
- People
- 1,050 worldwide
- Run by
- NYU Langone Health
See details and how to joinNCT07909395 - No phaseTaking peopleStudies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
- Where
- Bethesda, Washington D.C.
- Age
- 18 years to 120 years
- People
- 2,419
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00001281 - No phaseEnrolling by invitationAnalysis of HIV-1 Replication During Antiretroviral Therapy
- Where
- Bethesda
- Age
- 18 years to 99 years
- People
- 70
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00767312 - No phaseTaking peopleNatural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 700
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT01730131 - No phaseEnrolling by invitationORCHID: An Online Intervention for Persons With HIV (Miami)
- Where
- Miami
- Age
- 18 years to 90 years
- People
- 30
- Run by
- University of Miami
See details and how to joinNCT05935644 - Phase 2Taking peopleCASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
- Where
- San Francisco
- Age
- 21 years and over
- People
- 90 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT06949800 - Phase 1Not yet taking people in United StatesA Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
- Where
- Atlanta, Aurora, Birmingham, Boston, Chapel Hill, Chicago, Columbus, Houston, Philadelphia, San Diego
- Age
- 18 years to 70 years
- People
- 40 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06987318 - No phaseTaking peopleHIV/HBV/HCV Triple Screening in Primary Care
- Where
- Dallas
- Age
- 18 years and over
- People
- 50
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07031219 - Phase 1/2Taking peoplePrecision Microbiota Interventions for Senoreduction Trial
- Where
- New Orleans
- Age
- 40 years and over
- People
- 160
- Run by
- Louisiana State University Health Sciences Center in New Orleans
See details and how to joinNCT07462767 - Early phase 1Taking peopleA Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Where
- Baltimore, Chapel Hill, Chicago, Columbus, Houston, Miami, New York, Philadelphia, Salt Lake City
- Age
- 18 years and over
- People
- 15
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT04139304 - Phase 4Not yet taking people in United StatesStarting HIV Prevention Medicine (PrEP) During an Emergency Department Visit With a Peer Navigator
- Where
- Tampa
- Age
- 18 years and over
- People
- 50
- Run by
- University of South Florida
See details and how to joinNCT07901101 - No phaseTaking peopleLeukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 500
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00029445 - Phase 2Taking peopleDoravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Where
- Atlanta, Aurora
- Age
- 4 weeks to 11 years
- People
- 84 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04375800 - Phase 1Taking peopleDasatinib for HIV-1 Reservoir Reduction
- Where
- Chicago, Cleveland, Seattle
- Age
- 18 years and over
- People
- 14
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07342491 - Phase 1Taking peopleHEME-25 Open-Label Feasibility Study of Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
- Where
- Chicago
- Age
- 18 years and over
- People
- 17
- Run by
- University of Illinois Chicago
See details and how to joinNCT07647432 - No phaseNot yet taking people in United StatesSupporting Health and Empowerment Through Contingency Management and Affect Regulation
- Where
- Winston-Salem
- Age
- 18 years and over
- People
- 60
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07792161 - Phase 4Not yet taking people in United StatesReaching Persons With HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy - The RELAI Study
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 40
- Run by
- University of North Carolina, Chapel Hill
See details and how to joinNCT07895823 - No phaseTaking peopleScreen Smart: Using Digital Health to Improve HIV Screening and Prevention
- Where
- Columbus, Milwaukee, Philadelphia, Salt Lake City
- Age
- 15 years to 21 years
- People
- 63,000
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06003192 - Phase 1Taking peoplePhase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
- Where
- Atlanta, Boston, Nashville, Philadelphia, Pittsburgh, Rochester, San Francisco
- Age
- 18 years to 55 years
- People
- 54
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07757802